BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 10805101)

  • 1. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
    Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells.
    Bähr O; Rieger J; Duffner F; Meyermann R; Weller M; Wick W
    Brain Pathol; 2003 Oct; 13(4):482-94. PubMed ID: 14655754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.
    Etievant C; Barret JM; Kruczynski A; Perrin D; Hill BT
    Invest New Drugs; 1998; 16(1):3-17. PubMed ID: 9740539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of anticancer drugs in combination with nimodipine and verapamil on cultured cells of glioblastoma multiforme.
    Durmaz R; Deliorman S; Uyar R; Işiksoy S; Erol K; Tel E
    Clin Neurol Neurosurg; 1999 Dec; 101(4):238-44. PubMed ID: 10622452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
    Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
    Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status.
    Bartussek C; Naumann U; Weller M
    Exp Cell Res; 1999 Dec; 253(2):432-9. PubMed ID: 10585266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
    Breier A; Drobná Z; Barancík M
    Neoplasma; 1998; 45(4):248-53. PubMed ID: 9890669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
    Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
    Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
    Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
    Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitivity of human malignant glioma: modulation by p53 gene transfer.
    Trepel M; Groscurth P; Malipiero U; Gulbins E; Dichgans J; Weller M
    J Neurooncol; 1998 Aug; 39(1):19-32. PubMed ID: 9760067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.
    Nielsen D; Maare C; Eriksen J; Litman T; Skovsgaard T
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1050-7. PubMed ID: 11704330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation.
    Andersson U; Grankvist K; Bergenheim AT; Behnam-Motlagh P; Hedman H; Henriksson R
    Med Oncol; 2002; 19(1):1-9. PubMed ID: 12025885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo.
    Zhang DM; Shu C; Chen JJ; Sodani K; Wang J; Bhatnagar J; Lan P; Ruan ZX; Xiao ZJ; Ambudkar SV; Chen WM; Chen ZS; Ye WC
    Mol Pharm; 2012 Nov; 9(11):3147-59. PubMed ID: 23046348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells.
    Abe T; Hasegawa S; Taniguchi K; Yokomizo A; Kuwano T; Ono M; Mori T; Hori S; Kohno K; Kuwano M
    Int J Cancer; 1994 Sep; 58(6):860-4. PubMed ID: 7927879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance.
    Harbottle A; Daly AK; Atherton K; Campbell FC
    Int J Cancer; 2001 Jun; 92(6):777-83. PubMed ID: 11351295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the in vitro and in vivo properties of a (99m)Tc-labeled inhibitor of the multidrug resistant gene product P-glycoprotein.
    Bergmann R; Brust P; Scheunemann M; Pietzsch HJ; Seifert S; Roux F; Johannsen B
    Nucl Med Biol; 2000 Feb; 27(2):135-41. PubMed ID: 10773542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.